WALTHAM, Mass., Aug. 1, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Thursday, August 8 at 8:30 a.m. Eastern Time to discuss its second quarter 2013 financial results. The call and webcast will follow the release of second quarter financial results before the market opens.
Conference Call Details
To access the live conference call on August 8 at 8:30 a.m. Eastern Time via phone, please dial (877) 845-1016 from the U.S. and Canada, or (708) 290-1155 internationally. Please dial in approximately ten minutes prior to the start of the call.To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company's website http://investor.bg-medicine.com/events.cfm . Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary. About BG Medicine BG Medicine, Inc. (Nasdaq:BGMD) is a diagnostics company focused on the development and commercialization of novel cardiovascular tests to address significant unmet medical needs, improve patient outcomes and reduce healthcare costs. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit www.bg-medicine.com and www.galectin-3.com . The BG Medicine Inc. logo is available for download here
CONTACT: Media Contacts: For BG-Medicine: Chris Erdman, MacDougall Biomedical Communications,(781) 235-3060 BG-Medicine Investor Inquiries: Chuck Abdalian, EVP & Chief Financial Officer, (781) 434-0210